Similar results were obtained with macrophages deficient in cPLA2 at low and high A. phagocytophilum multiplicity of infection (MOI) (Fig 3A–3F and 3H), indicating that pharmacological inhibition of cPLA2 does not lead to off-target effects and the results obtained occurred independently of bacterial numbers. The gene discussed is PLA2G4A; the disease is infection.